LEP and breast cancer: Furthermore, LEP has been reported as a useful biomarker to differentiate BC patients according to its clinical characteristics (e.g., type, grade and stage) and also to classify tumors depending on their ER status, as ER− cases preferentially have higher LEP levels [70].